Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-677
Closed -$222K 119
2025
Q4
$222K Buy
+677
New +$215K 0.07% 112

Other funds holding AMGN

Vance Wealth's AMGN Position: Q1 2026 in Review

Vance Wealth sold out of Amgen (AMGN) in Q1 2026, closing a stake of 677 shares — an estimated $222K sold.

Vance Wealth first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $222K in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Vance Wealth reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Vance Wealth sold 677 Amgen shares in Q1 2026, an estimated $222K.
  • Vance Wealth first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
  • Vance Wealth's Amgen position peaked at $222K in Q4 2025.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Vance Wealth's 13F filing for Q1 2026, filed 15 May 2026.